Bullish
Steris plc reported higher revenue and adjusted earnings for fiscal 2025, keeping the infection prevention specialist on the radar of US healthcare in...
Neutral
Dana Investment Advisors Inc. grew its stake in STERIS plc (NYSE:STE – Free Report) by 88.9% during the fourth quarter, according to the company in it...
Neutral
Dana Investment Advisors Inc. significantly increased its stake in STERIS plc (NYSE:STE) by 88.9% in the fourth quarter, adding 39,753 shares to now h...
Neutral
This article provides details on the number of shareholders for STERIS plc (Ireland) under the NYSE ticker STE. It mentions that the data is sourced f...
Bullish
Steris plc has demonstrated steady growth in its latest quarterly report, with increased revenue and earnings, and its stock trading near recent highs...
Bearish
Stephens has lowered its price target for STERIS (STE) shares to $270 from $300, while reiterating an Overweight rating on the stock. This adjustment ...
Bearish
Jefferies has lowered its price target for STERIS (STE) from $253 to $225, while maintaining a Hold rating on the stock. This adjustment comes alongsi...
Neutral
Representative Gilbert Ray Cisneros, Jr. recently purchased shares of STERIS plc (NYSE:STE) valued between $1,001 and $15,000. This transaction was pa...
Neutral
Steris plc (NYSE:STE) is set to release its Q4 fiscal 2026 earnings today, May 11, with analysts expecting $1.60 billion in revenue and $2.89 EPS. The...
Neutral
Generali Asset Management SPA SGR reduced its stake in STERIS plc by 34.4% in the fourth quarter, selling 5,230 shares and retaining 9,963 shares valu...
Bullish
Analysts have assigned STERIS plc (NYSE:STE) a consensus "Moderate Buy" rating, with an average 12-month price target of $275.20. Institutional invest...
Neutral
Representative April McClain Delaney (D-Maryland) recently purchased between $1,001 and $15,000 worth of STERIS plc (NYSE:STE) stock on April 30, 2026...
Bullish
The Medical Device Cleaning Market is experiencing significant growth, projected to reach USD 5.79 billion by 2033 with a 9.8% CAGR, driven by infecti...
Neutral
STERIS plc has appointed Pierre Boulud, CEO of bioMérieux, to its Board of Directors, effective Tuesday. Boulud brings extensive leadership experience...
Neutral
Swedbank AB increased its stake in STERIS plc (NYSE:STE) by 5.7% during the fourth quarter, purchasing an additional 14,500 shares. This brings their ...
Neutral
Danske Bank A/S reduced its stake in STERIS plc by 28.7% in Q4, selling 22,251 shares and now holding 55,410 shares valued at approximately $14.05 mil...
Vanguard Capital Management has disclosed a 7.48% passive stake in STERIS plc (NYSE:STE), a move that could influence investor perception given STERIS...